Xhale Assurance nasal alar pulse oximetry sensor. Credit: Koninklijke Philips N.V.

Royal Philips has acquired US-based sensor technologies developer Xhale Assurance as part of its strategy to expand its monitoring & analytics business.

Financial details of the transaction have not been disclosed.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Xhale Assurance developed a disposable pulse oximetry sensor to measure and transmit patients’ heart rate and blood oxygenation data in low perfusion conditions.

“Philips expects Xhale’s technology to bolster its oxygen saturation monitoring solutions portfolio.”

Xhale sensor is said to accurately measure at lower oxygen saturation levels, which is considered critical for patients who have had a heart attack or hypoxic event.

The sensor also delivers early warning signals to caregivers in case of impending adverse events.

Philips expects Xhale’s technology to bolster its oxygen saturation monitoring solutions portfolio.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Royal Philips Monitoring & Analytics business leader Felix Baader said: “Xhale Assurance’s nasal alar sensor offers exceptional clinical capabilities and strengthens our patient monitoring offering with a next-generation pulse oximetry sensor technology.

“The sensor technology also offers opportunities to develop measurements of further physiologic parameters.”

Baader added that the sensor will help the company in providing solutions that will improve patient safety and caregiver efficiency, as well as support clinical workflow.

Philips patient monitoring portfolio is said to address any type of acuity level and care setting in hospitals and health systems. These solutions are used to monitor more than 275 million patients a year.

The portfolio of patient monitoring solutions includes bedside and wearable patient monitors, along with consumables such as connected wearable biosensors.

Philips also offers clinical decision support tools and mobile applications to capture clinical information in real-time at the patient’s bedside.